Emerging Roles of the Single EF-hand Ca2+ Sensor Tescalcin in the Regulation of Gene Expression, Cell Growth and Differentiation
Overview
Affiliations
Tescalcin (TESC, also known as calcineurin-homologous protein 3, CHP3) is a 24-kDa EF-hand Ca-binding protein that has recently emerged as a regulator of cell differentiation and growth. The TESC gene has also been linked to human brain abnormalities, and high expression of tescalcin has been found in several cancers. The expression level of tescalcin changes dramatically during development and upon signal-induced cell differentiation. Recent studies have shown that tescalcin is not only subjected to up- or down-regulation, but also has an active role in pathways that drive cell growth and differentiation programs. At the molecular level, there is compelling experimental evidence showing that tescalcin can directly interact with and regulate the activities of the Na/H exchanger NHE1, subunit 4 of the COP9 signalosome (CSN4) and protein kinase glycogen-synthase kinase 3 (GSK3). In hematopoetic precursor cells, tescalcin has been shown to couple activation of the extracellular signal-regulated kinase (ERK) cascade to the expression of transcription factors that control cell differentiation. The purpose of this Commentary is to summarize recent efforts that have served to characterize the biochemical, genetic and physiological attributes of tescalcin, and its unique role in the regulation of various cellular functions.
CCAR-1 works together with the U2AF large subunit UAF-1 to regulate alternative splicing.
Lugano D, Barrett L, Chaput D, Park M, Westerheide S RNA Biol. 2023; 21(1):1-11.
PMID: 38126797 PMC: 10761121. DOI: 10.1080/15476286.2023.2289707.
Stroma-associated FSTL3 is a factor of calcium channel-derived tumor fibrosis.
Li J, Liu Y, Yin Y, Li R, Huang W, Zou X Sci Rep. 2023; 13(1):21317.
PMID: 38044354 PMC: 10694158. DOI: 10.1038/s41598-023-48574-8.
Conformational regulation and target-myristoyl switch of calcineurin B homologous protein 3.
Becker F, Fuchs S, Refisch L, Drepper F, Bildl W, Schulte U Elife. 2023; 12.
PMID: 37435805 PMC: 10368425. DOI: 10.7554/eLife.83868.
Guo Y, Cai Y, Song F, Zhu L, Hu Y, Liu Y Endocrine. 2023; 81(3):503-512.
PMID: 37020077 DOI: 10.1007/s12020-023-03350-6.
Zou X, Zhou Q, Nie Y, Gou J, Yang J, Zhu J BMC Cancer. 2022; 22(1):595.
PMID: 35641944 PMC: 9158259. DOI: 10.1186/s12885-022-09643-9.